Looking for a less risky way to find growth stocks amid all the artificial intelligence hype? The answer may lie overseas. Nicholas Anderson, a portfolio manager and managing director at Thornburg Investment Management, outlined a group of European stocks with the potential for faster earnings growth than that offered by the tech-focused " Magnificent 7 " stocks that have dominated the domestic market in the U.S.
, Anderson said, naming them as his favorites in the group. Europe's largest software company, Germany's SAP , is also fueling the group's earnings as it works to migrate customers to more profitable cloud subscriptions. Novo has a "first-mover advantage" in the market for GLP-1 diabetes and obesity drugs, Anderson said. Novo manufactures weight loss drug Wegovy and diabetes drug Ozempic, which have seen rampant demand.
said on Monday that it opened a test laboratory with Belgium chip research firm Imec for its High NA EUV lithography equipment, a first-of-its-kind $380 million system that can produce chips at nodes even smaller than two nanometers . One nanometer equals one billionth of a meter.
대한민국 최근 뉴스, 대한민국 헤드 라인
Similar News:다른 뉴스 소스에서 수집한 이와 유사한 뉴스 기사를 읽을 수도 있습니다.
These dividend stocks top Thornburg's list — and they are trading at a discountInvestors searching for income can find some bargains in dividend stocks, according to Ben Kirby, co-head of investments at Thornburg Investment Management.
더 많은 것을 읽으십시오 »
AI Insights For Executives: Business Lessons From The Magnificent 7At C200, we embody the motto 'success shared,' leading in our mission to inspire, educate, support, and advance current and future women entrepreneurs and corporate, profit-center leaders. Our membership shares expertise, experience, networks, and leadership to support women's personal and professional growth in business.
더 많은 것을 읽으십시오 »